Eye Health Supplements

Eye Health Supplements

Global Eye Health Supplements Market to Reach US$2.9 Billion by 2030

The global market for Eye Health Supplements estimated at US$2.1 Billion in the year 2023, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Tablet, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Capsule segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$551.1 Million While China is Forecast to Grow at 7.3% CAGR

The Eye Health Supplements market in the U.S. is estimated at US$551.1 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$629.8 Million by the year 2030 trailing a CAGR of 7.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Eye Health Supplements Market - Key Trends and Drivers Summarized

How Are Eye Health Supplements Revolutionizing Vision Care and Preventing Age-Related Vision Loss?

Eye health supplements are playing a crucial role in revolutionizing vision care by providing essential nutrients that help maintain healthy vision and prevent age-related vision issues such as macular degeneration, cataracts, and dry eyes. With the increasing prevalence of eye disorders due to aging populations, lifestyle changes, and environmental factors such as prolonged screen exposure, the demand for effective eye health supplements is growing. These supplements are typically formulated with vitamins, minerals, antioxidants, and other nutrients known to support ocular health. Key ingredients include vitamins A, C, and E, zinc, lutein, zeaxanthin, and omega-3 fatty acids, all of which are critical for maintaining the structure and function of the eyes.

The introduction of eye health supplements is transforming how individuals manage their vision, particularly in the context of age-related eye conditions like age-related macular degeneration (AMD) and cataracts. AMD, for instance, is one of the leading causes of vision impairment in older adults. Research shows that certain nutrients, particularly lutein and zeaxanthin, which are found in high concentrations in the retina, can help protect the eyes from oxidative stress and blue light exposure, both of which are factors in the progression of AMD. Similarly, omega-3 fatty acids help support the lipid layer of the tear film, providing relief from dry eyes and reducing inflammation. As vision care becomes a greater priority, particularly with aging populations, eye health supplements are becoming an essential component of preventive eye care strategies.

Why Are Eye Health Supplements Critical for Maintaining Vision and Preventing Eye Disorders?

Eye health supplements are critical for maintaining vision and preventing eye disorders because they provide essential nutrients that may be lacking in a person’s diet, yet are necessary for proper eye function. Many eye disorders, particularly those associated with aging, such as macular degeneration and cataracts, are linked to oxidative damage caused by free radicals. Antioxidants like vitamins C and E, lutein, and zeaxanthin found in eye supplements help neutralize free radicals, reducing oxidative stress and protecting delicate eye tissues such as the retina and lens from damage. This is particularly important for individuals at risk of AMD, a degenerative condition that affects the macula, the part of the retina responsible for central vision. Studies have shown that high doses of antioxidants and zinc can slow the progression of AMD, helping patients maintain their vision for longer periods.

In addition to their protective antioxidant properties, many eye health supplements contain nutrients that support overall eye function and health. For instance, vitamin A is crucial for maintaining the health of the cornea and is also involved in the production of rhodopsin, a protein that helps the eyes adjust to low-light conditions. Zinc plays a vital role in transporting vitamin A from the liver to the retina, where it is used to produce melanin, a protective pigment. Omega-3 fatty acids, such as DHA (docosahexaenoic acid), are important for maintaining the structural integrity of retinal cells and promoting proper eye lubrication. These nutrients not only help prevent degenerative eye conditions but also provide relief for individuals suffering from dry eye syndrome, which has become increasingly common due to excessive screen use. Eye health supplements, therefore, offer a convenient and effective way to ensure that the eyes receive the nutrients they need to stay healthy and function optimally.

What Are the Expanding Applications and Innovations in Eye Health Supplements Across Different Demographics?

The applications of eye health supplements are expanding across various demographics, from aging populations to younger individuals experiencing digital eye strain, as awareness of vision health grows. Aging adults, who are more susceptible to conditions like AMD, cataracts, and glaucoma, represent the largest consumer base for these supplements. With age-related macular degeneration being one of the leading causes of blindness in older adults, supplements containing lutein, zeaxanthin, and zinc are increasingly prescribed as part of age-related eye disease management strategies. The Age-Related Eye Disease Study (AREDS) conducted by the National Eye Institute provided strong evidence that these nutrients, along with vitamins C, E, and copper, significantly reduce the risk of advanced AMD in individuals with high-risk factors. As a result, many supplements now follow the AREDS formula, tailored specifically to address age-related vision deterioration.

Younger adults, particularly those in the workforce who spend extended periods in front of digital screens, are also turning to eye health supplements to combat the effects of blue light exposure and digital eye strain. Prolonged screen use can lead to eye fatigue, dryness, and blurred vision, which are symptoms of digital eye strain. Supplements rich in lutein and zeaxanthin, two carotenoids that naturally filter blue light, are becoming popular among individuals seeking relief from the discomfort associated with heavy screen time. Additionally, omega-3 fatty acids are being used to help alleviate dry eye symptoms, a condition that is exacerbated by staring at screens for long periods without blinking. The growing trend of using digital devices for work, entertainment, and communication is driving the demand for eye health supplements in younger populations, highlighting the broadening scope of these products.

Innovation in the eye health supplement industry is also driving new product development tailored to specific needs. Manufacturers are now offering targeted formulations that address different aspects of eye health, from blue light protection to dry eye relief and support for overall retinal health. Moreover, advancements in nutraceuticals are leading to the development of supplements with enhanced bioavailability, allowing for better absorption and effectiveness of key nutrients. Some supplements are incorporating patented ingredients like FloraGLO® lutein, which has been clinically shown to improve macular pigment levels, thereby providing superior protection against oxidative damage and blue light. Additionally, there is increasing interest in combining eye health supplements with other wellness products, such as multivitamins or brain health supplements, to provide holistic support for both vision and cognitive function. These innovations are expanding the applications of eye health supplements, making them relevant across different age groups and lifestyles.

What Factors Are Driving the Growth of the Eye Health Supplements Market?

The growth of the eye health supplements market is being driven by several key factors, including the aging global population, rising awareness of age-related eye diseases, increased screen usage leading to digital eye strain, and a growing focus on preventive healthcare. One of the most significant drivers is the increasing prevalence of age-related eye conditions, such as macular degeneration, cataracts, and glaucoma, particularly in developed regions with aging populations. As people live longer, the incidence of these conditions is rising, prompting a greater demand for supplements that can help delay the onset or progression of vision loss. The Age-Related Eye Disease Study (AREDS) has been instrumental in raising awareness about the benefits of supplements in slowing the progression of AMD, leading to a surge in demand for supplements containing antioxidants, zinc, and other key nutrients.

Another factor contributing to the growth of the eye health supplements market is the widespread use of digital devices, which has led to an increase in digital eye strain or computer vision syndrome. As more people spend extended hours in front of screens—whether for work, entertainment, or communication—the symptoms of eye fatigue, dryness, and discomfort have become more common. Supplements containing lutein, zeaxanthin, and omega-3 fatty acids are being marketed as solutions to help protect the eyes from blue light and reduce the strain associated with prolonged screen use. The growing awareness of the impact of blue light on eye health, particularly among younger demographics, is fueling demand for products that offer protection against the harmful effects of modern digital lifestyles.

Preventive healthcare is another significant driver of the eye health supplements market. Consumers are increasingly focused on maintaining their health and wellness proactively, seeking out dietary supplements as part of a broader approach to long-term health management. Eye health supplements, which are often included in this proactive health regimen, appeal to individuals who want to maintain healthy vision as they age or reduce the risk of developing eye problems later in life. Additionally, the convenience of over-the-counter eye health supplements allows individuals to incorporate vision care into their daily routines easily, further boosting their popularity.

Technological advancements in supplement formulation and delivery are also driving market growth. Improved manufacturing techniques, such as microencapsulation, have enhanced the stability and bioavailability of key ingredients like lutein and zeaxanthin, making supplements more effective and easier for the body to absorb. Moreover, the availability of customized or personalized supplements tailored to specific nutritional needs is increasing consumer interest in eye health products. With the integration of wearable health tech and digital health platforms, individuals can now monitor their health more closely, further driving the demand for supplements that support their wellness goals.

In conclusion, the eye health supplements market is experiencing substantial growth due to the rising awareness of the importance of maintaining vision health, the increasing prevalence of age-related eye diseases, and the growing need for protection against digital eye strain. With continued innovation in product formulations and an expanding consumer base that spans different age groups and lifestyles, eye health supplements are set to remain a vital component of both preventive and therapeutic vision care strategies in the years to come. As demand for holistic health solutions continues to grow, eye health supplements will play an increasingly important role in helping individuals maintain healthy vision and quality of life.

Select Competitors (Total 46 Featured) -
  • Alliance Pharma Plc
  • Amway Corporation
  • Novartis AG
  • Pfizer, Inc.
  • The Nature's Bounty Co.
  • Valeant Pharmaceuticals International, Inc.
  • Vitabiotics Ltd.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Eye Health Supplements – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Prevalence of Vision Impairment and Eye Diseases Driving Demand for Eye Health Supplements
Advancements in Nutritional Science Enhancing Effectiveness of Eye Health Formulas
Increasing Consumer Awareness of Preventive Health Care Fueling Supplement Use
Impact of Aging Populations Globally on Eye Health Supplement Markets
Market Trends Toward Organic and Natural Ingredient-Based Supplements
Influence of Digital Screen Exposure on the Growing Demand for Eye Supplements
Expansion of Distribution Channels Including Online Retail Boosting Accessibility
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Eye Health Supplements Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Eye Health Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Eye Health Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Eye Health Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Tablet by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Tablet by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Tablet by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Capsule by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Capsule by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Capsule by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Other Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Age-related Macular Degeneration (AMD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Age-related Macular Degeneration (AMD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Age-related Macular Degeneration (AMD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Dry Eye Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Dry Eye Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Dry Eye Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Cataract by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Cataract by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Cataract by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Inflammation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Inflammation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Inflammation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 29: USA Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: USA Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: USA 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 32: USA Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: USA Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: USA 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
CANADA
TABLE 35: Canada Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: Canada Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: Canada 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 38: Canada Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: Canada 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
JAPAN
Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 41: Japan Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: Japan Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: Japan 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 44: Japan Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: Japan Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Japan 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
CHINA
Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 47: China Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: China Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: China 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 50: China Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: China Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: China 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
EUROPE
Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 53: Europe Recent Past, Current & Future Analysis for Eye Health Supplements by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Eye Health Supplements by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Europe 16-Year Perspective for Eye Health Supplements by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 56: Europe Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: Europe Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: Europe 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 59: Europe Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: Europe Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Europe 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
FRANCE
Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 62: France Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: France Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: France 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 65: France Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: France Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: France 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
GERMANY
Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 68: Germany Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Germany Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Germany 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 71: Germany Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: Germany Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Germany 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
ITALY
TABLE 74: Italy Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: Italy Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: Italy 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 77: Italy Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: Italy Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: Italy 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
UNITED KINGDOM
Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 80: UK Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: UK Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: UK 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 83: UK Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: UK Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: UK 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
SPAIN
TABLE 86: Spain Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Spain Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Spain 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 89: Spain Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Spain Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Spain 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
RUSSIA
TABLE 92: Russia Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Russia Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Russia 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 95: Russia Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Russia Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Russia 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: Rest of Europe Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Rest of Europe 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Rest of Europe Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Rest of Europe 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Eye Health Supplements by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for Eye Health Supplements by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: Asia-Pacific 16-Year Perspective for Eye Health Supplements by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Asia-Pacific Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Asia-Pacific 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: Asia-Pacific Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: Asia-Pacific 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
AUSTRALIA
Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 113: Australia Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 114: Australia Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: Australia 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 116: Australia Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: Australia Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: Australia 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
INDIA
Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 119: India Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 120: India Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 121: India 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 122: India Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 123: India Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 124: India 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 125: South Korea Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 126: South Korea Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 127: South Korea 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 128: South Korea Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 129: South Korea Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 130: South Korea 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 132: Rest of Asia-Pacific Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 135: Rest of Asia-Pacific Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
LATIN AMERICA
Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 137: Latin America Recent Past, Current & Future Analysis for Eye Health Supplements by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 138: Latin America Historic Review for Eye Health Supplements by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 139: Latin America 16-Year Perspective for Eye Health Supplements by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 140: Latin America Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 141: Latin America Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 142: Latin America 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 143: Latin America Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 144: Latin America Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 145: Latin America 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 146: Argentina Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 147: Argentina Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 148: Argentina 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 149: Argentina Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 150: Argentina Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 151: Argentina 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
BRAZIL
TABLE 152: Brazil Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 153: Brazil Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 154: Brazil 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 155: Brazil Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 156: Brazil Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 157: Brazil 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
MEXICO
TABLE 158: Mexico Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 159: Mexico Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 160: Mexico 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 161: Mexico Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 162: Mexico Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 163: Mexico 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 165: Rest of Latin America Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 166: Rest of Latin America 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 168: Rest of Latin America Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 169: Rest of Latin America 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
MIDDLE EAST
Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 170: Middle East Recent Past, Current & Future Analysis for Eye Health Supplements by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 171: Middle East Historic Review for Eye Health Supplements by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 172: Middle East 16-Year Perspective for Eye Health Supplements by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 173: Middle East Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 174: Middle East Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 175: Middle East 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 176: Middle East Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 177: Middle East Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 178: Middle East 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
IRAN
TABLE 179: Iran Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 180: Iran Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 181: Iran 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 182: Iran Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 183: Iran Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 184: Iran 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
ISRAEL
TABLE 185: Israel Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 186: Israel Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 187: Israel 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 188: Israel Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 189: Israel Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 190: Israel 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 192: Saudi Arabia Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 193: Saudi Arabia 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 195: Saudi Arabia Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 196: Saudi Arabia 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 197: UAE Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 198: UAE Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 199: UAE 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 200: UAE Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 201: UAE Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 202: UAE 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 204: Rest of Middle East Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 205: Rest of Middle East 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 207: Rest of Middle East Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 208: Rest of Middle East 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
AFRICA
Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 209: Africa Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 210: Africa Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 211: Africa 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
TABLE 212: Africa Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 213: Africa Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 214: Africa 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings